Results of shared learning of a new radiofrequency identification localization device-a UK iBRA-NET breast cancer localisation study

Clin Radiol. 2024 Nov;79(11):e1288-e1295. doi: 10.1016/j.crad.2024.06.014. Epub 2024 Jul 2.

Abstract

Introduction: Localisation methods for surgical excision of impalpable breast lesions have advanced in recent years, with increasing utilization of new wire-free technologies. The Hologic LOCalizer™ radiofrequency identification (RFID) tag is one such device; however, as is the case when new technologies are first introduced, little is known about clinical experiences, potential complications, and learning used to overcome perioperative challenges when changing from guidewires to RFID tags. This study reports shared learning experiences of clinicians using the LOCalizer™ as part of the national iBRA-NET localisation study.

Methods: This mixed-methods study captured shared-learning themes relating to LOCalizer™ usage as part of a multicentre prospective registry study, which collected data on each LOCalizer™ placement. Prospective, anonymized clinical and demographic data were collected and managed using a Research Electronic Data Capture (REDCap) database. Shared learning was captured prospectively as part of the registry study between January 2021 and July 2022, combined with a virtual qualitative webinar-style focus group. Learning events were then coded, grouped by theme, and suggestions for practice were produced.

Results: Twenty-four UK breast units submitted data on 1188 patient records pertaining to RFID-guided localisation between January 2021 and July 2022, of which 59 (5.0%) included a shared-learning event. The virtual webinar was attended by 108 healthcare professionals, including oncoplastic breast surgeons and breast radiologists. Shared-learning themes were categorized into preoperative, intraoperative, and postoperative events.

Conclusions: By sharing learning outcomes associated with localisation techniques in this paper, the aim is to shorten the learning curve and potential for adverse events for users new to the LOCalizer™ technique.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Breast / diagnostic imaging
  • Breast / surgery
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / surgery
  • Female
  • Humans
  • Middle Aged
  • Prospective Studies
  • Radio Frequency Identification Device*
  • Registries*
  • United Kingdom